Abstract
Frequencies of the carriership of alleles and genotypes of functionally important polymorphous loci of some inflammation genes (proinflammatory cytokine genes IL-6, LTA, and TNF; anti-inflammatory cytokine gene TGFB1; and CC chemokine receptor 5 gene CCR5) were analyzed in 199 ethnic Russian patients with myocardial infarction (MI) and in a control group of 142 persons of the same ethnic descent. Complex analysis by the APSampler algorithm revealed associations of MI with the carriership of all polymorphic variants either regarded as individual risk factors (insertion-deletion polymorphism of CCR5 and SNP G252A LTA) or in combination with other alleles or genotypes. The carriership of bi-or triallelic combinations was associated with MI more reliable than the carriership of any subsets: single alleles or allele pairs. The protective triallelic combination d*CCR5 + 252G*LTA + -174C*Il-6 was found to be the most significant (p = 0.0006, OR = 0.23, CI = 0.090–0.56). Separate analysis of genetic susceptibility to MI in men and women demonstrated sexual dimorphism for the CCR5 gene.
Similar content being viewed by others
References
Shevchenko O.P., Mishnev O.D. 2005. Ishemicheskaya bolezn’ serdtsa (Ischemic Heart Disease). Moscow: Reafarm.
Ross R. 1999. Atherosclerosis is an inflammatory disease. Am. Heart J. 138, S419–S420.
Tabas I. 2009. Macrophage death and defective inflammation resolution in atherosclerosis. Nature Rev. Immunol. 10, 36–46.
Foteinos G., Xu Q. 2009. Immune-mediated mechanisms of endothelial damage in atherosclerosis. Autoimmunity. 42, 627–633.
Topol E.J. 2006. The genetics of heart attack. Heart. 92, 855–861.
Casas J.P., Cooper J., Miller G.J., Hingorani1 A.D., Humphries S.E. 2006. Investigating the genetic determinants of cardiovascular disease using candidate genes and meta-analysis of association studies. Ann. Hum. Genetics. 70, 145–169.
Baudhuin L.M. 2009. Genetics of coronary artery disease: focus on genomewide association studies. Am. J. Transl.Res. 1, 221–234.
Spiridonova M.G., Stepanov V.A., Puzyrev V.P., Karpov R.S. 2002. Analysis of gene complexes predisposing to coronary atherosclerosis. Russ. J. Genet. 38, 300–308.
Dankovtseva E.N., Zateishchikov D.A., Chudakova D.A., Koroleva O.S., Brovkin A.N.,Nosikov V.V., Gaidukova N.V., Tishchenko V.A., Sidorenko B.A. 2005. Association of hemostasis factor genes with early development of ischemic heart diseases and manifestations of myocardial infarction at young age. Kardiologiya. 45, 17–24.
Pchelina S.N., Sirotkina O.V., Sheidina A.M., Taraskina A.E., Rodygina T.I., Demina E.P., Zabotina A.M., Mitupova M.I., Bazhenova E.A., Berkovich O.A. 2007. Genetic factors of risk for development of myocardial infarction in young men living in northwestern Russia. Kardiologiya. 47, 29–34.
Voevoda M.I., Kulikov I.V., Maksimov V.N., Malyutina S.K., Schachtschneider E.V., Kulishova L.M., Novoselov V.P., Romashchenko A.G. 2009. Instant cardiac death and polymorphism of candidate genes for cardiovascular diseases. Kardiologiya. 49, 52–57.
Sirotkina O.V., Zabotina A.M., Berkovich O.A., Bazhenova E.A., Vavilova T.V., Shvartsman A.L. 2009. Genetic variants of platelet ADP receptor P2Y12 associated with changed platelet functional activity and development of cardiovascular diseases. Genetika. 45, 247–253.
Gukova S.P., Fomicheva E.V., Kovalev Yu.P. 1997. Role of structural polymorphism of the angiotensin-onverting enzyme in the development of myocardial infarction. Klin Med. 75, 36–39.
Berkovich O.A., Bazhenova E.A., Volkova E.A., Alugishvili M.Z., Kiselev I.O., Smirnov B.I., Shvarts E.I., Shlyakhto E.V. 2001. The I/D polymorphism of angiotensin-converting enzyme gene in young men with myocardial infarction. Ross. Fiziol. Zh. im. M.M. Sechenova. 87, 642–648.
Spiridonova M.G., Stepanov VA., Puzyrev V.P., Kosyankova T.V., Karpov R.S. 2001. Association between polymorphism T174M ofthe angiotensinogen gene and coronary atherosclerosis in the Tomsk population. Mol. Biol. 35, 11–14.
Nikitin A.G., Gorashko N.M., Minushkina L.O., Kudryashova O.Yu., Zateishchikov D.A., Sidorenko B.A., Nosikov V.V. 2003. Association of the G7831A polymorphism ofthe ACE gene with coronary heart disease in muscovites. Mol. Biol. 37, 49–51.
Babunova N.B., Minushkina L.O., Zateishchikov D.A., Sidorenko B.A., Nosikov V.V. 2003. Association ofthe T174M and M235T polymorphisms of the angiotensinogen gene with coronary heart disease in ethnic Russians from Moscow. Mol. Biol. 37, 52–55.
Sheidina A.M., Pchelina S.N., Demidova D.M., Rodygina Tl., Tarashkina A.E., Toperverg O.B., Berkovich O.A., Demina E.V., Shvarts E.I., Pogoda T.V., Generozov E.V., Govorun V.M., Lopukhin Yu.M., Shevchenko Yu.A. 2004. Analysis of allele frequencies of four single-nucleotide polymorphisms in the 50-untranslated region of the ABCA1 gene in young men with myocardial infarction. Kardiologiya. 44, 40–45.
Zateyshchikov D.A., Dankovtseva E.N., Nikitin A.G., Koroleva O.S., Brovkin A.N., Yakunina N.Yu., Chudakova D.A., Nosikov V.V., Sidorenko B.A. 2006. Genetic predisposition to early onset of coronary artery disease. Atherosclerosis. 7, S131.
Shevtsov S.P., Kuchinskii A.P., Dzeranova N.Ya., Ktsoeva T.V., Fomicheva K.V., Kovalev Yu.R., Shvarts E.I. 1994. Analysis of polymorphisms of apoB and apoC3 apolipoprotein genes in patients with myocardial infarction. Mol. Genet. Mikrobiol. Virusol. 3, 33–36.
Volkova M.V., Vasina V.I, Fomicheva E.V, Schwartz E.I. 1997. Comparative analysis of apo(a) gene alleles: Distribution of pentanucleotide repeats in position — 1373 and C/T transition in position +93 among patients with myocardial infarction and a control group in St. Petersburg, Russia. Biochem. Mol. Med. 61, 208–213.
Stepanov V.A., Puzyrev V.P., Karpov R.S., Kutmin A.I. 1998. Genetic markers in coronary artery disease in a Russian population. Hum. Biol. 70, 47–57.
Shagisultanova E.I., Mustafina O.E., Tuktarova I.A., Khusnutdinova E.K. 2001. HindIII polymorphism of lipoprotein lipase gene and the risk of myocardial infarction. Mol. Genet. Mikrobiol. Virusol. 3, 18–22.
Mustafina O.E., Shagisultanova E.I., Tuktarova I.A., Khusnutdinova E.K. 2002. Polymorphism of the apolipoprotein E gene and risk of myocardial infarction. Mol. Biol. 36, 792–797.
Voevoda M.I., Stepanov V.A., Romashchenko A.G., Maksimov V.N. 2006. Specific ethnogenetic features of susceptibility to atherosclerosis in ethnic groups of Siberia (the example of apolipoprotein E gene). Byull. Sib. Otd. Ross. Akad. Med. Nauk. 2, 63–72.
Kuz’mina A.A., Latfulin I.A. 1998. HLA haplotypes in young patients with myocardial infarction. Terapevt. Arkhiv. 70, 33–37.
Voevoda M.I., Ustinov S.N., Yudin N.S., Dolgikh M.M., Kuznetsova T.N., Maksimov V.N., Kulikov I.V., Gromov A.A., Shabalin A.V., Semaeva E.V., Kobzev V.F., Baum S.R., Gafarov VV, Malyutina S.K., Romaschenko A.G., Nikitin Y. 2002. Association of the CCR2 chemokine receptor gene polymorphism with myocardial infarction. Dokl. Biol. Sci. 385, 367–370.
Tereshchenko I.P., Petrkova J., Mrazek F., Lukl J., Maksimov V.N., Romaschenko A.G., Voevoda M.I., Petrek M. 2009. The macrophage migration inhibitory factor (MIF) gene polymorphism in Czech and Russian patients with myocardial infarction. Clin. Chim. Acta. 402, 199–202.
Konenkov V.I., Rakova I.G., Maksimov V.N., Voevoda M.I. 2006. Allelic polymorphism of genes for pro-and anti-inflammatory cytokines in a Caucasoid male population. Byull. Sib. Otd. Ross. Akad. Med. Nauk. 2, 56–62.
Sambrook J., Fritsch E.F., Maniatis T. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Lab. Press.
He B., Navikas V., Lundah, J., Söderström M., Hillert J. 1995. Tumor necrosis factor alpha-308 alleles in multiple sclerosis and optic neuritis. J. Neuroimmunol. 63, 143–147.
Roth M.P., Nogueira L., Coppin H., Clanet M., Clayton J., Cambon-Thomsen A. 1994. Tumor necrosis factor polymorphism in multiple sclerosis: No additional association independent of HLA. J. Neuroimmunol. 51, 93–99.
Sandford A.J., Pare P.D. 1997. Direct PCR of small genomic DNA fragments from serum. Biotechniques. 23, 890–892.
DeMichele A, Martin A.M., Mick R, Gor R, Wray L., Klein-Cabral M., Athanasiadis G., Colligan T, Stadtmauer E., Weber B. 2003. Interleukin-6 174G3C polymorphism is associated with improved outcome in high-risk breast cancer. Cancer Res. 63, 8051–8056.
Favorov A.V., Andreewski T.V., Sudomoina M.A., Favorova O.O., Parmigiani G., Ochs M.F. 2005. A Markov chain Monte Carlo technique for identification of combinations of allelic variants underlying complex diseases inhumans. Genetics. 171, 2113–2121.
O’Doherty C., Favorov A., Heggarty S., Graham C., Favorova O., Ochs M., Hawkins S., Hutchinson M., O’Rourke K., Vandenbroeck K. 2009. Genetic polymorphisms, their allele combinations, and IFN-beta treatment response in Irish multiple sclerosis patients. Pharmacogenomics. 10, 1177–1186.
Chikhladze N.M., Samedova Kh.F., Sudomoina M.A., Ko Min, Koliadina Yu.A., Litonova G.N., Favorov A.V., Chazova I.E., Favorova O.O. 2008. Comparative genetic analysis of different forms of Iow-renin arterial hypertension. Mol. Biol. 42, 521–530.
Favorova O.O., Favorov A.V., Boiko A.N., Andreewski T.V., Sudomoina M.A., Alekseenkov A.D., Kulakova O.G., Gusev E.I., Parmigiani G., Ochs M.F. 2006. Three allele combinations associated with multiple sclerosis. BMCMed. Genet. 26, e63.
Parfenov M.G., Titov B.V., Sudomoina M.A., Martynov M.Yu., Favorov A.V., Ochs M.F., Gusev E.I., Favorova O.O. 2009. Genetic susceptibility to ischemic stroke in Russians. Mol. Biol. 43, 873–880.
Ozaki K., Ohnishi Y., Iida A., Sekine A., Yamada R., Tsunoda T., Sato H., Sato H., Hori M., Nakamura Y., Tanaka T. 2002. Functional SNPs in the lymphotoxinalpha gene that are associated with susceptibility to myocardial infarction. Nature Genet. 32, 650–654.
Laxton R., Pearce E., Kyriakou T, Ye S. 2005. Association of the lymphotoxin-alpha gene Thr26Asn polymorphism with severity of coronary atherosclerosis. Genes Immun. 6, 539–541.
Clarke R., Xu P., Bennett D., Lewington S., Zondervan K., Parish S., Palmer A., Clark S., Cardon L., Peto R. 2006. Lymphotoxin-alpha gene and risk of myocardial infarction in 6928 cases and 2712 controls in the ISIS casecontrol study. PLoS Genet. 2, e107.
Auer J., Weber T, Berent R., Lassnig E., Lamm G., Eber B. 2003. Genetic polymorphisms in cytokine and adhesion molecule genes in coronary artery disease. Am. J. Pharmacogenomics. 3, 317–328.
Gonzalez R, Alvarez R., Batalla A., Reguero J.R., Alvarez V., Astudillo A., Cubero G.I., Cortina A., Coto E. 2001. Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction. Genes Immun. 2, 191–195.
Barbaux S., Tregouet D.A., Nicaud V, Poirier O., Perret C., Godefroy T., Francomme C., Combadiere C., Arveiler D., Luc G., Ruidavets J.B., Evans A.E, Kee F., Morrison C, Tiret L., Brand-Herrmann S.M., Cambien F. 2007. Polymorphisms in 33 inflammatory genes and risk of myocardial infarction: A system genetics approach. J. Mol. Med. 85, 1271–1280.
Licastro F., Chiapelli M., Caldarera C.M., Caruso C., Lio D., Corder E.H. 2007. Acute myocardial infarction and proinflammatory gene variants. Ann. N. Y. Acad. Sci. 1119, 227–242.
Bis J.C., Heckbert S.R., Smith N.L., Reiner A.P., Rice K., Lumley T., Hindorff L.A., Marciante K.D., Enquobahrie D.A., Monks S.A., Psaty B.M. 2008. Variation in inflammation-related genes and risk of incident nonfatal myocardial infarction or ischemic stroke. Atherosclerosis. 198, 166–173.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © M.A. Sudomoina, T.S. Sukhinina, R.M. Barsova, A.V. Favorov, R. M. Sakhnovich, B.V. Titov, N.A. Matveeva, I.N. Rybalkin, T.N. Vlasik, M.F. Ochs, M. Ya. Ruda, O.O. Favorova, 2010, published in Molekulyarnaya Biologiya, 2010, Vol. 44, No. 3, pp. 463–471.
Rights and permissions
About this article
Cite this article
Sudomoina, M.A., Sukhinina, T.S., Barsova, R.M. et al. Complex analysis of association of inflammation gene polymorphisms with myocardial infarction. Mol Biol 44, 407–414 (2010). https://doi.org/10.1134/S0026893310030088
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026893310030088